These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 16368282)
1. The cost-effectiveness analysis (CEA) is dependent on the quality of the NEPHRIC study. Hocher B Am Heart J; 2006 Jan; 151(1):e5; author reply e7. PubMed ID: 16368282 [No Abstract] [Full Text] [Related]
2. Cost-effectiveness analysis (CEA) health economic point of view. Fricke FU Am Heart J; 2006 Jan; 151(1):e1; author reply e3. PubMed ID: 16368280 [No Abstract] [Full Text] [Related]
3. The safety and cost-effectiveness of low osmolar contrast media. Benness GT Med J Aust; 1991 Nov; 155(9):646-8. PubMed ID: 1943970 [No Abstract] [Full Text] [Related]
4. [Selection of contrast media: current status of understanding]. Briguori C G Ital Cardiol (Rome); 2009 Feb; 10(2):79-87. PubMed ID: 19348144 [TBL] [Abstract][Full Text] [Related]
5. Acute kidney injury with iodinated contrast. McCullough PA Crit Care Med; 2008 Apr; 36(4 Suppl):S204-11. PubMed ID: 18382195 [TBL] [Abstract][Full Text] [Related]
6. A case for nonionic contrast media--despite the high cost. Lieberman EB; Bashore TM J Crit Illn; 1992 Dec; 7(12):1853-4, 1860. PubMed ID: 10148097 [No Abstract] [Full Text] [Related]
7. Do benefits of contrast outweigh its costs? Cosgrove DO; Blomley MJ Diagn Imaging (San Franc); 1996 Sep; Suppl():AU31-2. PubMed ID: 10170152 [No Abstract] [Full Text] [Related]
8. Cost-effectiveness of hemofiltration to prevent contrast nephropathy in patients with chronic kidney disease. Klarenbach SW; Pannu N; Tonelli MA; Manns BJ Crit Care Med; 2006 Apr; 34(4):1044-51. PubMed ID: 16484907 [TBL] [Abstract][Full Text] [Related]
9. Iodinated contrast media and the kidney. Weisbord SD Rev Cardiovasc Med; 2008; 9 Suppl 1():S14-23. PubMed ID: 18418313 [TBL] [Abstract][Full Text] [Related]
10. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects. Solomon R; Dumouchel W Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749 [TBL] [Abstract][Full Text] [Related]
11. Iodinated contrast media and contrast-induced nephropathy: is there a preferred cost-effective agent? Sharma SK J Invasive Cardiol; 2008 May; 20(5):245-8. PubMed ID: 18460711 [TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of low osmolality contrast media. Hlatky MA J Am Coll Cardiol; 1993 Jun; 21(7):1710-1. PubMed ID: 8496541 [No Abstract] [Full Text] [Related]